Tamura K, Mukohara T, Yonemori K, Kawabata Y, et al. Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2). Breast Cancer 2023 Mar 29. doi: 10.1007/s12282-023-01443.
PMID: 36977973